Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Targeted Cancer Therapies & Biofluid Biopsies

Targeted Cancer Therapies & Biofluid Biopsies

Keynote Speakers

Swapna Chaudhuri
Professor, Calcutta School of Tropical Medicine

Ashish Gautam
Global Brand Medical Head - ADCETRIS, Takeda Oncology

Rajiv Raja
Director, MedImmune/ AstraZeneca


After the last year's event on Biofluid Biopsies in Bengaluru, SELECTBIO brings to you an enhanced version of the same event on Cancer Diagnosis and Treatment. The event  has been entitled "Targeted Cancer Therapies and Biofluid Biopsies". 

The event aims to bring together different fraternities of scientists who are working towards Cancer diagnosis and selective treatment of cancer. Targetted cancer therapies include Cancer immunotherapy, Hormone therapy, ADC, Apoptosis inducers, Angiogenesis inhibitors, ST inhibitors and Gene therapy. The session on Biofluid biopsies will focus primarily on blood-based molecular biomarkers such as Circulating Tumor DNA (ctDNA) for developing biological fluid-based biopsies as well as Circulating Tumor Cells (CTCs) and Protein-based Circulating Biomarkers. 

This event is beneficial for the Scientists who are working or planning to work in the area of extracellular nucleic acids, extracellular vesicles, circulating cell free DNA, microRNA, Liquid biopsies etc. 

This conference will provide scientists and researchers with most up-to-date information & emerging trends in the area of Cancer Therapies and Biofluid Biopsies. Open discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the Targetted Cancer Therapies and Circulating Biomarkers Landscape, especially in the Indian context.

Venue and Dates: Le Méridien Bangalore Hotel, Bengaluru, India on May 25-26, 2017

Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Agenda Topics

  • Antibodies and Antibody Drug Conjugates for Cancer Therapeutics
  • Cancer Immunotherapy
  • Circulating Cells & Nucleic Acids as Biomarkers
    • CTCs, cfDNA, exRNA, EVs
  • Current Targetted Cancer Therapies
    • Angiogenesis Inhibitors
    • Apoptosis Inducers
    • Hormone Therapies
    • Signal Transduction Inhibitors
  • Emerging Technology Platforms for Developing Biofluid-based Biopsies
  • Gene Therapy and Cancer Vaccines
  • Targeted Cancer Drug Delivery Systems

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Distinguished Faculty

Susanna T, Assistant Professor, Sri Devaraj Urs Medical College
Neha Garg, Assistant Professor, IIT Mandi
Hirak Basu, Associate Professor, University of Texas MD Anderson Cancer Center
Sunil J Advani, Associate Professor & Associate Division Director Clinical and Translational Research, University of California, San Diego
Vishwas Joshi, Director, Seagull BioSolutions Pvt Ltd
Aditi Chatterjee, Faculty Scientist, Institute of Bioinformatics
Shibichakravarthy Kannan, Founder & CEO, Theranosis Life Sciences Pvt Ltd
Somnath Mondal, PhD Fellow, Calcutta School of Tropical Medicine, Kolkata
Maria Kowal, Protein Scientist, Piramal Pharma Solutions
Saritha Surapaneni, Research Scholar, Acharya Bm Reddy College of Pharmacy
Sudheer Kumar Katari, Research Scholar, Sri Venkateswara Institute of Medical Sciences University
Tejaswini Subbannayya, Research Scientist, Institute of Bioinformatics
Jason Ross, Sr Research Scientist And Team Leader, Commonwealth Scientific and Industrial Research Organisation
Lydia Charles, Student, Bharathiar University
Olivier Pardo, Team Leader, Imperial College London

Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks